RxDoctor Payments Data

Mikayla Heronimus, PA

Physician Assistant · Sioux Falls, SDNPI 1205460862

Payments from drug & device makers

$779in general payments, 2019–2025

Across 31 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$258
  • Sanofi$125
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$117
  • Kiniksa Pharmaceuticals International, PLC$60
  • E.r. Squibb & Sons, L.L.C.$32
  • Abiomed$32
  • plus $155 from 8 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$779 in reported general payments places this provider in the 75th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$5,115
Medicare patients
64
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban216$204,318
EliquisApixaban183$152,311
Repatha SureclickEvolocumab46$28,399
EntrestoSacubitril/Valsartan22$24,869
Repatha SyringeEvolocumab31$17,722
Praluent PenAlirocumab26$12,408
BrilintaTicagrelor23$12,264
FarxigaDapagliflozin Propanediol17$9,551
Metoprolol Succinate283$4,526
Flecainide Acetate75$3,102
Atorvastatin Calcium329$2,986
Rosuvastatin Calcium180$2,782
Diltiazem 24hr Er (Cd)Diltiazem Hcl112$2,102
Ezetimibe74$2,007
Metoprolol Tartrate319$1,698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$258$204,318216 claims
PfizerEliquis$14$152,311183 claims
NovartisEntresto$22$24,86922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →